Pheophorbide a identified in an Eupatorium perfoliatum extract is a novel lymphatic vascular activator

The lymphatic vascular system is crucial for maintaining tissue fluid homeostasis and immune surveillance. Promoting lymphatic function represents a new strategy to treat several diseases including lymphedema, chronic inflammation and impaired wound healing. By screening a plant extract library, a petroleum ether extract from the aerial parts of Eupatorium perfoliatum (E. perfoliatum) was found to possess lymphangiogenic properties. With the aid of HPLC activity profiling the active compound was identified as pheophorbide a. Both plant extract and pheophorbide a induced the sprouting and tube formation of human primary lymphatic endothelial cells (LECs). The proliferation of the LECs was increased upon treatment with pheophorbide a but not the E. perfoliatum extract. Treatment with the MEK1/2 inhibitor U0126 reduced the LEC sprouting activity, indicating a potential mechanism of action. These studies suggest that pheophorbide a could represent novel natural therapeutic agent to treat human lymphatic vascular insufficiencies.

Automated summary

The lymphatic vascular system plays a crucial role in maintaining tissue fluid homeostasis and immune surveillance. Promoting lymphatic function can be a new approach to treat various diseases. Through screening of plant extracts, pheophorbide a was identified as a compound that can induce lymphangiogenesis. Pheophorbide a may serve as a novel natural therapeutic agent to treat human lymphatic vascular insufficiencies.